Article
作者: Desestret, Virginie ; Scharf, Madeleine ; Zorn, Kelsey C. ; Pleasure, Samuel J. ; Antoine, Jean-Christophe ; DeRisi, Joseph L. ; Wilson, Michael R ; Do, Le-Duy ; Gelfand, Jeffrey M. ; Gelfand, Jeffrey M ; Peter, Elise ; Rogemond, Véronique ; Tranchant, Christine ; DeRisi, Joseph L ; Farina, Antonio ; Pleasure, Samuel J ; Miske, Ramona ; Bartley, Christopher M ; Wilson, Michael R. ; Ngo, Thomas ; Ciano-Petersen, Nicolas Lundahl ; Pluvinage, John ; Dubois, Valérie ; Zorn, Kelsey C ; Perrot, Jimmy ; Bartley, Christopher M. ; Villagrán-García, Macarena ; Honnorat, Jérôme ; Traverse-Glehen, Alexandra
AbstractAtaxia with anti-regulator of G-protein signaling 8 autoantibodies (RGS8-Abs) is an autoimmune disease recently described in four patients. The present study aimed to identify other patients with RGS8-Abs, describe their clinical features, including the link between RGS8-related autoimmune cerebellar ataxia (ACA) and cancer. Patients with RGS8-Abs were identified retrospectively in the biological collections of the French Reference Center for Paraneoplastic Neurological Syndrome and the University of California San Francisco Center for Encephalitis and Meningitis. Clinical data were collected, and cerebrospinal fluid, serum, and tumor pathological samples were retrieved to characterize the autoantibodies and the associated malignancies. Only three patients with RGS8-Abs were identified. All of them presented with a pure cerebellar ataxia of mild to severe course, unresponsive to current immunotherapy regimens for ACA. Two patients presented with a Hodgkin lymphoma of the rare specific subtype called nodular lymphocyte-predominant Hodgkin lymphoma, with very mild extension. Autoantibodies detected in all patients enriched the same epitope on the RGS8 protein, which is an intracellular protein physiologically expressed in Purkinje cells but also ectopically expressed specifically in lymphoma cells of patients with RGS8-related ACA. The present results and those of the four cases previously described suggest that RGS8-Abs define a new paraneoplastic neurological syndrome of extreme rarity found mostly in middle-aged males that associates pure cerebellar ataxia and a particular lymphoma specifically expressing the RGS8 antigen. As in other paraneoplastic ACA with intracellular antigen, the disease course is severe, and patients tend to exhibit a poor response to immune therapy.